Equities

Falco Holdings Co Ltd

Falco Holdings Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (JPY)2,295.00
  • Today's Change15.00 / 0.66%
  • Shares traded8.10k
  • 1 Year change+19.04%
  • Beta0.5187
Data delayed at least 20 minutes, as of May 16 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

FALCO HOLDINGS Co.,Ltd is a Japan-based company mainly engaged in the clinical testing business and the dispensing pharmacy business. The Company operates in two business segments. The Clinical Testing segment is engaged in the contracted clinical specimen testing business for hospitals and clinics, as well as the development and sale of electronic medical charts and other medical information systems, and the wholesale of in-vitro diagnostic drugs. The Dispensing Pharmacy segment is engaged in the operation of dispensing pharmacies.

  • Revenue in JPY (TTM)43.01bn
  • Net income in JPY1.67bn
  • Incorporated1982
  • Employees1.16k
  • Location
    Falco Holdings Co Ltd1-3-7, Uchihirano-machi, Nakagyo-kuOSAKA-SHI 540-0037JapanJPN
  • Phone+81 676326150
  • Fax+81 752578511
  • Websitehttps://www.falco-hd.co.jp/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Living Platform Ltd15.79bn132.75m5.23bn1.02k39.553.3410.110.331429.4529.453,517.39348.491.40413.238.5115,435,750.001.181.991.682.848.5011.290.84071.681.05-4.280.81140.0017.8019.25-77.523.7417.23--
Advantage Risk Management Co., Ltd.7.00bn505.58m7.07bn391.0013.501.7110.331.0130.2930.29419.43238.511.12--6.76--8.097.7212.3812.1570.4974.077.227.42----0.079740.089.267.4033.89-3.8436.783.71
Uchiyama Holdings Co Ltd28.84bn213.92m7.31bn2.33k30.570.52938.580.253311.0611.061,490.07638.540.9427102.3211.39--0.6992-2.040.9815-2.767.295.430.7417-2.271.5922.360.5216--7.181.17153.40-27.96-9.990.00
As Partners Co Ltd17.15bn563.57m7.46bn835.0010.87--13.160.4352193.24193.246,503.80------------------18.13--3.29----15.56----34.17--145.34------
Care Twentyone Corp42.07bn-38.76m7.90bn5.91k--1.355.220.1877-2.87-2.873,121.08395.281.17749.337.537,123,649.00-0.12241.48-0.17351.9621.6622.97-0.10441.431.03-0.85880.785737.347.037.89-99.02-50.6624.669.43
Japan Hospice Holdings Inc10.35bn669.37m12.24bn963.0018.124.1811.051.1882.0682.061,267.69355.740.7351--6.8810,749,690.004.754.435.425.2918.1519.686.475.49--3.270.78680.0025.0526.7749.9535.4787.38--
StemCell Institute Inc2.48bn310.98m18.66bn92.0060.006.9354.497.5230.3530.35242.15262.780.401722.191.82--5.034.2312.0510.8563.5164.4012.5310.411.19--0.00330.0018.6416.6357.0416.8446.68--
Falco Holdings Co Ltd43.01bn1.67bn25.43bn1.16k15.170.941112.680.5913151.32151.323,894.772,438.541.1420.606.67--4.435.795.757.9530.0531.283.884.662.29--0.030430.17-8.33-0.5259-26.3220.600.893711.70
CellSource Co Ltd4.62bn851.00m28.12bn151.0032.344.7230.286.0843.9143.91237.98300.970.8246.0213.4830,626,030.0015.1619.2316.7122.5768.5370.7518.4020.218.20--0.0012.895.5430.04-9.3036.7070.54--
I'rom Group Co Ltd17.74bn1.42bn34.33bn894.0023.802.6419.121.93116.87116.871,465.201,054.900.490913.335.02--3.926.945.979.8742.3143.177.9811.341.18--0.609829.64-3.3310.89-44.349.1816.6114.87
Gakken Holdings Co Ltd176.45bn3.73bn44.14bn9.49k11.630.79565.610.250285.0785.074,026.331,243.071.309.956.4018,592,940.003.102.614.873.9928.1029.172.381.951.1516.990.437333.865.188.93-7.150.8741-7.847.39
Charm Care Corp44.99bn3.93bn51.49bn2.00k13.113.1510.691.14120.02120.021,375.72499.010.99594.4915.2322,537,580.008.697.1316.9510.7218.0117.388.737.860.7114104.060.508620.3330.3222.798.6239.0916.0254.49
CUC Inc33.02bn2.60bn54.01bn2.99k20.211.9312.241.6489.0989.091,135.93931.800.6438294.863.89--5.08--7.24--48.21--7.90--2.09--0.4883---6.21--7.10------
Data as of May 16 2024. Currency figures normalised to Falco Holdings Co Ltd's reporting currency: Japanese Yen JPY

Institutional shareholders

7.43%Per cent of shares held by top holders
HolderShares% Held
Nomura Asset Management Co., Ltd.as of 30 Apr 2024285.10k2.57%
Dimensional Fund Advisors LPas of 09 May 2024153.77k1.39%
Nikko Asset Management Co., Ltd.as of 10 May 2024134.90k1.22%
Daiwa Asset Management Co. Ltd.as of 29 Mar 2024127.30k1.15%
Mitsubishi UFJ Asset Management Co., Ltd.as of 10 May 202456.40k0.51%
BlackRock Japan Co. Ltd.as of 09 May 202417.00k0.15%
Dimensional Fund Advisors Ltd.as of 29 Feb 202413.79k0.12%
Asset Management One Co., Ltd.as of 09 May 202413.70k0.12%
Sumitomo Mitsui Trust Asset Management Co., Ltd.as of 20 Apr 202313.70k0.12%
DFA Australia Ltd.as of 31 Mar 20247.43k0.07%
More ▼
Data from 31 Mar 2024 - 16 May 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.